Gender-related differences in vascular smooth muscle cell proliferation: implications for prevention of arteriosclerosis

Abstract

Premenopausal women have a significant reduction in coronary artery disease compared to age matched males. Little is known about the mechanism underlying this cardio protective effect of estrogen. Contradictory evidence has been published and our lack of basic understanding of hormone interactions and bioavailability of different estrogens prevents definitive interpretation of these data. We demonstrate gender-specific effects in the proliferation of coronary artery vascular smooth muscle cells obtained from a sexually mature animal model. Vascular smooth muscle cells are an integral component of the atherosclerotic plaque, and inhibition of cell proliferation by estrogen may be one mechanism by which estrogen exerts its cardio protective effect. Various types of estrogen may also have different mechanistic actions on the vascular system. No differences are demonstrated in overall estradiol binding in vascular smooth muscle cells obtained from male or female animals; however, differences in c-jun, c-fos and TIEG gene expression were gender related. Inhibition of vascular smooth muscle cell proliferation may have important implications in the prevention of atherosclerotic disease and these studies may provide evidence for the cardio protective effect of estrogen.

Keywords

estrogen athersclerosis vascular biology

Get full access to this article

View all access options for this article.

References

Fitzpatrick LA . Editorial: Coronary artery disease in women-An equal opportunity killer . J Clin Endocrinol Metab 1998; 83: 719–720 .

Stampfer MJ , Colditz GA . Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence . Prev Med 1991; 20: 47–63 .

Barrett-Connor E . Sex differences in coronary heart disease . Circulation 1997; 95: 252–264 .

Grodstein, F , Stampfer MJ , Colditz GA . Postmenopausal hormone therapy and mortality . N Engl J Med 1997; 336: 1769–1775 .

Hulley S , Grady D , Bush T et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women . JAMA 1998; 280: 605–613 .

Severson AR , Ingram RT , Fitzpatrick LA . Matrix proteins associated with bone calcification are present in human vascular smooth muscle cells grown in vitro . In Vitro Cell Dev Biol 1995; 31: 853–857 .

Raines EW , Ross R . Smooth muscle cells and the pathogenesis of the lesion of arteriosclerosis . Br Heart J 1993; 69 (Suppl): S30–S37

Moraghan T , Antoniucci DM , Grenert JP et al. Differential response in cell proliferation to beta estradiol in coronary artery vascular smooth muscle cells obtained from mature female versus male animals . Endocrinology 1996; 137: 5174–5177 .

Troy SM , Hicks DR , Parker VD et al. Differences in pharmacokinetics and comparative bioavailability between Premarin and Estratab in healthy postmenopausal women . Curr Ther Res 1994; 55: 359–372

10.

Gilligan DM , Badar DM , Panza JA et al. Acute vascular effects of estrogen in postmenopausal women . Circulation 1994; 90: 786–791 .

11.

Mueck AO , Seeger H , Lippert TH . Calcium antagonistic effect of natural and synthetic estrogens. Investigations on a nongenomic mechanism of direct vascular action . Int J Clin Pharmacol Ther 1996; 34: 424–426 .